9[9]Jacobsen P,Andersen S,Rossing K,et al.Dual blockade of the rennin angiotens in system versus maximal recommended dose of ACEI in diabetic nephropathy[J].Kidney Int,2003,63(5):1874.
10[10]Bakris GL,Weir MR,Shanifar S,et al.Effects of blood pressure level on progression of diabetic nephropathy:Results from the RENAAL study[J].Arch Intern Med,2003,163(12):1555.
7[1]Chobanian AV, Bakris GL, Black HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation,and Treatment of High Blood Pressure: the JNC 7 report [J ] .JAMA,2003,289(20) :2560 ～ 72.
8[2]Kidney Disease Outcomes Quality Initiative ( K/DOQI ) .K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease[J] .Am J Kidney Dis, 2004, 43(Suppl 1 ) :S1 ～ 290.
9[3]Flack JM, Peters R, Shafi T, et al.Prevention of hypertension and its complications: theoretical basis and guidelines for treatment [J]. J Am Soc Nephrol,2003,14(Suppl 2):S92～8.
10[5]Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men 16 year MRFIT findings [J] .JAMA,1997, 277(16): 1293 ～ 8.
